Repligen Corp. (RGEN)
115.55
-0.75
(-0.64%)
USD |
NASDAQ |
Mar 25, 13:36
Repligen EPS Diluted (Quarterly) : 0.2345 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Masimo Corp. | 1.311 |
| Orthofix Medical, Inc. | -0.0555 |
| InfuSystem Holdings, Inc. | 0.0966 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 13.29M |
| Revenue (Quarterly) | 197.91M |
| Total Expenses (Quarterly) | 184.63M |
| Enterprise Value | 6.474B |
| Gross Profit Margin (Quarterly) | 47.21% |
| Profit Margin (Quarterly) | 6.71% |
| Earnings Yield | 0.75% |
| Operating Earnings Yield | 0.78% |
| Normalized Earnings Yield | 0.7062 |